Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CDKN1B anticorps

CDKN1B Reactivité: Humain WB, ELISA Hôte: Chèvre Polyclonal unconjugated
N° du produit ABIN547623
  • Antigène Voir toutes CDKN1B Anticorps
    CDKN1B (Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B))
    Reactivité
    • 277
    • 129
    • 108
    • 26
    • 8
    • 6
    • 5
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 240
    • 52
    • 2
    • 1
    • 1
    Chèvre
    Clonalité
    • 232
    • 64
    Polyclonal
    Conjugué
    • 146
    • 24
    • 17
    • 16
    • 16
    • 14
    • 6
    • 6
    • 6
    • 6
    • 6
    • 6
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp CDKN1B est non-conjugé
    Application
    • 205
    • 134
    • 73
    • 62
    • 53
    • 41
    • 36
    • 26
    • 25
    • 16
    • 16
    • 13
    • 7
    • 7
    • 3
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Fonction
    Goat polyclonal antibody raised against synthetic peptide of CDKN1B.
    Séquence
    C-KRPATDDSST QNK
     Réactivité croisée
    Cat, Chien, Humain
    Attributs du produit
    Antibody Reactive Against Synthetic Peptide.
    Immunogène
    A synthetic peptide corresponding to human CDKN1B.
    Top Product
    Discover our top product CDKN1B Anticorps primaire
  • Indications d'application
    ELISA (1:32000)
    Western Blot (0.1-0.3 μg/mL)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.5 mg/mL
    Buffer
    In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Baldassarre, Belletti, Nicoloso, Schiappacassi, Vecchione, Spessotto, Morrione, Canzonieri, Colombatti: "p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion." dans: Cancer cell, Vol. 7, Issue 1, pp. 51-63, (2005) (PubMed).

  • Antigène
    CDKN1B (Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B))
    Autre désignation
    CDKN1B / KIP1 (CDKN1B Produits)
    Synonymes
    anticorps CDKN4, anticorps KIP1, anticorps MEN1B, anticorps MEN4, anticorps P27KIP1, anticorps cdkn1b, anticorps sb:cb611, anticorps wu:fb63g10, anticorps wu:fb64g10, anticorps wu:fe18e03, anticorps CDKN1B, anticorps Kip1, anticorps p27, anticorps FAM14D, anticorps ISG12, anticorps ISG12A, anticorps P27, anticorps Cdki1b, anticorps AA408329, anticorps AI843786, anticorps p27Kip1, anticorps cdkn1bl, anticorps cyclin dependent kinase inhibitor 1B, anticorps cyclin-dependent kinase inhibitor 1Bb, anticorps interferon alpha inducible protein 27, anticorps cyclin-dependent kinase inhibitor 1B, anticorps cyclin-dependent kinase inhibitor 1Ba, anticorps CDKN1B, anticorps cdkn1bb, anticorps IFI27, anticorps Cdkn1b, anticorps cdkn1ba
    ID gène
    1027
    Pathways
    Cycle Cellulaire, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Sensory Perception of Sound, Mitotic G1-G1/S Phases, DNA Replication, Positive Regulation of Endopeptidase Activity, Synthesis of DNA, Autophagy
Vous êtes ici:
Support technique